retatrutide and pregnancy Retatrutide, Breastfeeding Retatrutide for Post-Pregnancy Weight Loss:
Description
This was based largely on the FLOW trial, which found that patients with CKD and Type 2 diabetes who took semaglutide had a significantly lower risk of major kidney events (kidney failure, dialysis, transplant)
This trend aligns with broader increases in GLP-1 RA utilization across the general population during the same period ( 15 )
Harvard Khetrapal, Afsaneh
Its triple-agonist mechanism drives research interest in fat loss, muscle retention, and longevity across multiple scientific disciplines
